A protein promoted growth in lab-grown melanoma cells
Melanoma cells multiplied more in lab experiments with higher doses of spondin 1, a protein researchers attached to a surface.
Biological & Pharmaceutical Bulletin
In experiments with YUMM1.7 melanoma cells grown in the lab, researchers tested spondin 1, a protein. When attached to a surface, it promoted cell multiplication, with a stronger effect at higher doses.
In a melanoma model, the team traced cells using a labelling system linked to p16, a protein used to mark senescence, a state in which cells stop dividing. Fibroblasts, cells that help build tissue’s supporting structure, formed a major labelled population. The gene for spondin 1 was more active in labelled fibroblasts. A separate human skin tumour dataset also showed higher spondin 1 gene activity in fibroblasts, especially those expressing the gene for p16. In survival data, high spondin 1 gene activity was independently associated with shorter overall survival after accounting for tumour type, age and sex.
Why it matters
The work bears on how cells carrying a marker of senescence, a process relevant to aging, may influence the environment around a melanoma.
Caveats
The growth result came from cells grown in the lab. The survival link was observational and does not show that spondin 1 caused poorer outcomes.
The paper
Kanazawa University
Biological & Pharmaceutical Bulletin · 1 Jan 2026
